TSXV:BTI.H - Post by User
Comment by
JDavenporton Dec 16, 2022 2:58pm
93 Views
Post# 35176532
RE:Glioblastoma market US$4.2 billion in 2028
RE:Glioblastoma market US$4.2 billion in 2028It will be years before xB3 versions of Midatech's drugs can be designed, put through preclinical studies and then clinical trials. Over five years. That's a minimum.
Add that to the 15 years that Bioasis shareholders have....
Never mind.
jd